CN104328211B - PML-RARα融合基因的环介导等温扩增检测方法的引物和试剂盒 - Google Patents
PML-RARα融合基因的环介导等温扩增检测方法的引物和试剂盒 Download PDFInfo
- Publication number
- CN104328211B CN104328211B CN201410682429.3A CN201410682429A CN104328211B CN 104328211 B CN104328211 B CN 104328211B CN 201410682429 A CN201410682429 A CN 201410682429A CN 104328211 B CN104328211 B CN 104328211B
- Authority
- CN
- China
- Prior art keywords
- primer
- pml
- test kit
- seqidno
- nucleotide sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 34
- 101001095089 Homo sapiens PML-RARA-regulated adapter molecule 1 Proteins 0.000 title claims abstract description 28
- 102100037019 PML-RARA-regulated adapter molecule 1 Human genes 0.000 title claims abstract description 28
- 238000012360 testing method Methods 0.000 title claims abstract description 27
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 19
- 238000007397 LAMP assay Methods 0.000 title claims abstract description 15
- 230000004927 fusion Effects 0.000 title claims abstract description 14
- 238000006243 chemical reaction Methods 0.000 claims description 31
- 239000000376 reactant Substances 0.000 claims description 22
- 239000002773 nucleotide Substances 0.000 claims description 13
- 125000003729 nucleotide group Chemical group 0.000 claims description 13
- 239000013641 positive control Substances 0.000 claims description 13
- 239000013642 negative control Substances 0.000 claims description 12
- 230000014509 gene expression Effects 0.000 claims description 6
- DEGAKNSWVGKMLS-UHFFFAOYSA-N calcein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(CN(CC(O)=O)CC(O)=O)=C(O)C=C1OC1=C2C=C(CN(CC(O)=O)CC(=O)O)C(O)=C1 DEGAKNSWVGKMLS-UHFFFAOYSA-N 0.000 claims description 5
- 239000003153 chemical reaction reagent Substances 0.000 claims description 5
- 229960002378 oftasceine Drugs 0.000 claims description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 102100034343 Integrase Human genes 0.000 claims description 3
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 claims description 3
- 210000002966 serum Anatomy 0.000 claims description 3
- 229910021642 ultra pure water Inorganic materials 0.000 claims description 3
- 239000012498 ultrapure water Substances 0.000 claims description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 2
- 239000004471 Glycine Substances 0.000 claims description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims 1
- 230000001413 cellular effect Effects 0.000 claims 1
- 208000007660 Residual Neoplasm Diseases 0.000 abstract description 12
- 101150087698 alpha gene Proteins 0.000 abstract description 8
- 238000003199 nucleic acid amplification method Methods 0.000 abstract description 7
- 230000003321 amplification Effects 0.000 abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 6
- 208000032839 leukemia Diseases 0.000 abstract description 5
- 230000001154 acute effect Effects 0.000 abstract description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 19
- 238000000034 method Methods 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 8
- 239000000523 sample Substances 0.000 description 8
- 208000036762 Acute promyelocytic leukaemia Diseases 0.000 description 7
- 208000033826 Promyelocytic Acute Leukemia Diseases 0.000 description 7
- 239000006228 supernatant Substances 0.000 description 7
- 230000035945 sensitivity Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 206010000830 Acute leukaemia Diseases 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- 230000004544 DNA amplification Effects 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- WAEMQWOKJMHJLA-UHFFFAOYSA-N Manganese(2+) Chemical compound [Mn+2] WAEMQWOKJMHJLA-UHFFFAOYSA-N 0.000 description 2
- 102000006382 Ribonucleases Human genes 0.000 description 2
- 108010083644 Ribonucleases Proteins 0.000 description 2
- 238000003149 assay kit Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910001437 manganese ion Inorganic materials 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 239000011435 rock Substances 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- HJTAZXHBEBIQQX-UHFFFAOYSA-N 1,5-bis(chloromethyl)naphthalene Chemical compound C1=CC=C2C(CCl)=CC=CC2=C1CCl HJTAZXHBEBIQQX-UHFFFAOYSA-N 0.000 description 1
- 206010062489 Leukaemia recurrent Diseases 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- 230000018199 S phase Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- GOLCXWYRSKYTSP-UHFFFAOYSA-N arsenic trioxide Inorganic materials O1[As]2O[As]1O2 GOLCXWYRSKYTSP-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000011901 isothermal amplification Methods 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 208000025113 myeloid leukemia Diseases 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 101150022630 prp5 gene Proteins 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000011535 reaction buffer Substances 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 231100000004 severe toxicity Toxicity 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000017105 transposition Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410682429.3A CN104328211B (zh) | 2014-11-24 | 2014-11-24 | PML-RARα融合基因的环介导等温扩增检测方法的引物和试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410682429.3A CN104328211B (zh) | 2014-11-24 | 2014-11-24 | PML-RARα融合基因的环介导等温扩增检测方法的引物和试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104328211A CN104328211A (zh) | 2015-02-04 |
CN104328211B true CN104328211B (zh) | 2016-06-22 |
Family
ID=52403016
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410682429.3A Expired - Fee Related CN104328211B (zh) | 2014-11-24 | 2014-11-24 | PML-RARα融合基因的环介导等温扩增检测方法的引物和试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104328211B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111850131B (zh) * | 2020-08-26 | 2023-06-27 | 苏州卫生职业技术学院 | 一种检测pml-rara融合基因的lamp引物组、试剂盒及检测方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102399901A (zh) * | 2011-12-21 | 2012-04-04 | 中国人民解放军疾病预防控制所 | 结核杆菌的lamp检测方法及其专用引物与试剂盒 |
CN102424841A (zh) * | 2011-12-21 | 2012-04-25 | 中国人民解放军疾病预防控制所 | 旋毛虫的lamp检测方法及其专用引物与试剂盒 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004089089A (ja) * | 2002-08-30 | 2004-03-25 | Srl Inc | PML−RARAキメラmRNA測定用核酸及びそれを用いたPML−RARAキメラmRNAの測定方法 |
CN101341260B (zh) * | 2005-10-07 | 2014-02-12 | 强生研究有限公司 | 多组分核酸酶及其使用方法 |
CA2902167A1 (en) * | 2013-03-15 | 2014-09-25 | Abbott Molecular Inc. | Method for amplification and assay of rna fusion gene variants, method of distinguishing same and related primers, probes, and kits |
CN103725787B (zh) * | 2014-01-15 | 2015-07-22 | 湖南圣湘生物科技有限公司 | 一种白血病融合基因荧光pcr检测试剂盒 |
-
2014
- 2014-11-24 CN CN201410682429.3A patent/CN104328211B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102399901A (zh) * | 2011-12-21 | 2012-04-04 | 中国人民解放军疾病预防控制所 | 结核杆菌的lamp检测方法及其专用引物与试剂盒 |
CN102424841A (zh) * | 2011-12-21 | 2012-04-25 | 中国人民解放军疾病预防控制所 | 旋毛虫的lamp检测方法及其专用引物与试剂盒 |
Non-Patent Citations (1)
Title |
---|
Using reverse transcript loop-mediated isothermal amplification for rapid detection of PML-RARA fusion gene;Zhang Y,et al;《 JAPANESE JOURNAL OF CLINICAL HEMATOLOGY》;20121231;第53卷(第9期);PS-2-51 * |
Also Published As
Publication number | Publication date |
---|---|
CN104328211A (zh) | 2015-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Tan et al. | Recent advances in recombinase polymerase amplification: Principle, advantages, disadvantages and applications | |
Li et al. | Cas12aFDet: A CRISPR/Cas12a-based fluorescence platform for sensitive and specific detection of Listeria monocytogenes serotype 4c | |
CN108060257B (zh) | 一种基于环介导等温扩增技术检测强雄腐霉的引物组合物及其检测方法 | |
CN111235313A (zh) | 一种快速检测新型冠状病毒的CRISPR-Cas13方法 | |
CN112239795A (zh) | 基于rt-rpa和crispr的可视化新冠病毒rna核酸检测试剂盒 | |
CN102816847B (zh) | 用于检测布鲁氏菌的lamp引物及含有该引物的试剂盒 | |
CN113186313A (zh) | 基于RPA-LbCas12a-TTECDS体系的沙门氏菌检测引物组、方法与试剂盒 | |
CN105039322B (zh) | Dna标签序列及测序文库构建方法和试剂盒 | |
CN106868220A (zh) | 一种用于扩增MERS‑CoV的LAMP引物组及试剂盒 | |
Wang et al. | Primer dephosphorylation-initiated circular exponential amplification for ultrasensitive detection of alkaline phosphatase | |
Gou et al. | The colorimetric isothermal multiple-self-matching-initiated amplification using cresol red for rapid and sensitive detection of porcine circovirus 3 | |
CN103436602A (zh) | 双重分子信标-lamp法同时检测金黄色葡萄球菌基因和大肠杆菌基因的试剂盒及方法 | |
CN115820939A (zh) | 用于猴痘病毒检测的crRNA、核酸分子组合物、检测体系及应用 | |
Kim et al. | Advanced target‐specific probe‐based real‐time loop‐mediated isothermal amplification assay for the rapid and specific detection of porcine circovirus 3 | |
Wang et al. | A novel real-time reverse transcription loop-mediated isothermal amplification detection platform: application to diagnosis of COVID-19 | |
CN104328209B (zh) | 白血病微小残留病wt1基因快速检测方法的引物和试剂盒 | |
CN104328211B (zh) | PML-RARα融合基因的环介导等温扩增检测方法的引物和试剂盒 | |
Chen et al. | Smartphone-assisted fluorescence-based detection of sunrise-type smart amplification process and a 3D-printed ultraviolet light-emitting diode device for the diagnosis of tuberculosis | |
CN105039598A (zh) | 一种中东呼吸综合征冠状病毒ORF1a2基因检测试剂盒 | |
CN103698516A (zh) | 一种新型等温环介导鼠疫耶尔森菌核酸标记检测试剂 | |
CN104328210B (zh) | Aml1/eto融合基因的环介导等温扩增检测方法的引物和试剂盒 | |
CN104278024B (zh) | 用于鉴定人类腺病毒55型的引物组合物以及它们的应用 | |
CN108676921A (zh) | 一种用于禽腺病毒检测的lamp引物组及检测方法及其应用 | |
CN112980844A (zh) | 针对有转录活性的SARS-CoV-2的检测试剂盒和使用方法 | |
CN112126695A (zh) | 一种结核分枝杆菌复合群环介导等温扩增检测用引物组合物及反应体系 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210603 Address after: Room 1309, building 3, Dongdu International Plaza, 88 Gongye North Road, Licheng District, Jinan City, Shandong Province, 250132 Patentee after: Shandong ShuoKe Biotechnology Co.,Ltd. Patentee after: BEIJING LANPU BIOTECHNOLOGY DEVELOPMENT Co.,Ltd. Address before: No.18877, Jingshi Road, Lixia District, Jinan City, Shandong Province, 250062 Patentee before: INSTITUTE OF BASIC MEDICINE, SAMS Patentee before: BEIJING LANPU BIOTECHNOLOGY DEVELOPMENT Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160622 |
|
CF01 | Termination of patent right due to non-payment of annual fee |